We have located links that may give you full text access.
Case Reports
Journal Article
Review
Collagenous crystalloids in myoepithelial carcinoma: report of a case and review of the literature.
American Journal of Clinical Pathology 2008 September
Since the first report of "tyrosine crystals" in a parotid mixed tumor by Bullock in 1953, authors have described several types of crystalloids in association with mixed tumor and related neoplastic and nonneoplastic entities. The principal classes of these include tyrosine-rich crystalloids, collagenous crystalloids, and one class variously referred to as tyrosine-rich crystals, nontyrosine crystalloids, and amylase crystalloids. We report a myoepithelial carcinoma of minor salivary gland origin containing numerous collagenous crystalloids. To our knowledge, this represents the first report of collagenous crystalloids in a case of myoepithelial carcinoma. In addition, we searched our institution's files for cases of pure myoepithelial tumors. No crystalloids of any form were identified in 27 myoepitheliomas and 15 myoepithelial carcinomas. We review the literature on salivary-related crystalloids, and we propose the term oncocyte/cyst-associated crystalloids to encompass the aforementioned third class of crystalloid. Given distinct morphologic and histochemical properties and given relatively limited disease associations, we conclude that in the appropriate clinical context, the identification of these crystalloids can be diagnostically useful.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app